$INNV Following Its Recent Approval from Health Canada for the Relief of Neuropathy Pain, Innovus Pharma Announces Receipt of Notification to Commercialize Diabasens® in the European Union.

https://www.otcmarkets.com/stock/INNV/news/Fo...?id=229545